neutral
3 days agoNephro Health IPO sees muted demand on second day of bidding
Investor response to Nephro Health’s mainboard IPO remained subdued on Day 2, with overall subscription reaching just 0.32 times. Retail investors subscribed 0.39 times, QIBs 0.30 times, and NIIs 0.17 times, while the employee quota was nearly fully subscribed. The IPO closes on December 12. Grey market premium stands at Rs 20, implying a potential listing near Rs 480, around 4.3% above the issue price of Rs 460.
Tags:
- nephro health
- ipo subscription
Explore:Mutual Fund Tools
neutral
3 days agoNephro Health IPO sees muted demand on second day of bidding
Investor response to Nephro Health’s mainboard IPO remained subdued on Day 2, with overall subscription reaching just 0.32 times. Retail investors subscribed 0.39 times, QIBs 0.30 times, and NIIs 0.17 times, while the employee quota was nearly fully subscribed. The IPO closes on December 12. Grey market premium stands at Rs 20, implying a potential listing near Rs 480, around 4.3% above the issue price of Rs 460.
Tags:
- nephro health
- ipo subscription
Explore:High Return Equity Mutual Fund
Recently
1 min read
68 words
Nephro Health’s IPO continued to see weak demand on Day 2, with limited subscription across categories despite a modest grey market premium.
Investor response to Nephro Health’s mainboard IPO remained subdued on Day 2, with overall subscription reaching just 0.32 times. Retail investors subscribed 0.39 times, QIBs 0.30 times, and NIIs 0.17 times, while the employee quota was nearly fully subscribed. The IPO closes on December 12. Grey market premium stands at Rs 20, implying a potential listing near Rs 480, around 4.3% above the issue price of Rs 460.
Investor response to Nephro Health’s mainboard IPO remained subdued on Day 2, with overall subscription reaching just 0.32 times. Retail investors subscribed 0.39 times, QIBs 0.30 times, and NIIs 0.17 times, while the employee quota was nearly fully subscribed. The IPO closes on December 12. Grey market premium stands at Rs 20, implying a potential listing near Rs 480, around 4.3% above the issue price of Rs 460.
Tags:
- nephro health
- ipo subscription
- nephro health
- ipo subscription
- gmp
- healthcare stocks
Dec 12, 2025 • 05:15